Omnicell

SEPTEMBER 5, 2022

Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. billion in associated costs.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell 52

Omnicell

SEPTEMBER 5, 2022

David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell 52

Omnicell

SEPTEMBER 5, 2022

In fact, in a 2020 ISMP Sterile Compounding Pulse Check conducted with 634 pharmacy practitioners, only 25% of respondents report using technologies that include barcode verification, images, and gravimetric verification for 50% of compounded sterile products.

Compounding 52

Compounding Sterile Compounds Compounding Pharmacies Documentation 52